Skip to content

OTC vs. Listed Options: Terms, Clearing, Credit, and Exit

For educational purposes only; not investment advice.

A listed option is admitted to trading under an exchange’s rules and, for U.S. listed options accepted by OCC, enters a central-clearing framework. Its series terms, quotation, exercise, assignment, adjustment, and settlement follow exchange and OCC rules. Fungibility and multivenue markets can support closing trades without negotiating with the original counterparty.

An over-the-counter (OTC) option is negotiated bilaterally under a legal agreement. It can tailor notional, dates, strike, exercise schedule, payoff, currency, settlement, collateral, termination events, and other terms, but valuation, credit support, closeout, netting, and dispute procedures depend on the agreement and counterparties.

The boundary is not simply standardized versus customized. Exchange FLEX options allow rule-based customization while retaining listed-market and clearing features, and some OTC derivatives may be centrally cleared. Always identify the exact contract, venue, governing documents, and actual clearing path.

Dimension Listed option Bilateral OTC option
Terms Exchange-defined series or permitted FLEX elections Negotiated confirmation and master agreement
Execution Exchange order book, auction, or approved mechanism Request for quote or direct negotiation
Counterparty path Broker, clearing member, and central counterparty after clearing acceptance Named counterparty unless a clearing arrangement changes the path
Credit support Clearing-member margin and default resources; separate customer broker requirements Contractual collateral, thresholds, eligible assets, haircuts, netting, guarantees
Valuation Observable quotes may exist, but depth and marks can still be weak Model and dealer marks may dominate; valuation-agent and dispute terms matter
Exit Offset in the fungible market, exercise, or expiration Assignment, novation, unwind, termination, or offset as the contract permits
Documentation Exchange/OCC rules plus broker agreement Master agreement, schedule, confirmation, credit-support and other documents

Central clearing changes the counterparty structure; it does not remove market, liquidity, funding, member, operational, or model risk. Bilateral collateral and netting can reduce OTC credit exposure; they do not guarantee immediate recovery, especially during valuation disputes, collateral timing gaps, closeout stays, or insolvency.

A simplified current replacement-exposure screen is:

unsecured current exposure = max(positive contract value − enforceable netting − collateral held, 0)

This is not a complete credit model. Future exposure, collateral haircuts, settlement timing, wrong-way risk, legal enforceability, closeout method, currency mismatch, concentration, and recovery all remain. A negative mark can create posting or funding obligations rather than receivable exposure.

Customized hedge with residual credit exposure

Section titled “Customized hedge with residual credit exposure”

A company buys a three-year customized option from a bank to hedge a cash flow whose date, currency, and notional do not match a standard listed series. Later, the contract has a positive replacement value of $2.4 million to the company. It holds $1.5 million of eligible collateral and has an enforceable $0.3 million payable to the same counterparty inside the applicable netting set.

The simplified current unsecured exposure is:

max($2.4m − $1.5m − $0.3m, 0) = $0.6m

That $0.6 million is not the option’s market loss and not an expected recovery amount. It is a snapshot of positive replacement value not covered by the stated netting and collateral assumptions. A market move before the next margin call, a disputed mark, collateral haircut, unenforceable netting, or delayed closeout can increase the realized shortfall.

A listed alternative might offer transparent series and central clearing but fail to match the exact date, notional, currency, or payoff. Using several listed contracts could introduce basis and rollover risk. The correct comparison includes hedge mismatch, execution and unwind cost, collateral funding, documentation, counterparty concentration, and operational capacity—not premium alone.

  • Write every economic term: underlying, notional, multiplier, strike, observation, barrier, exercise, expiration, settlement, currency, calendar, and disruption event.
  • Identify exchange, clearing organization, clearing member, broker, legal counterparties, guarantors, and custody path.
  • For OTC, review master agreement, schedule, confirmation, credit-support terms, netting set, valuation agent, dispute process, termination events, governing law, and closeout currency.
  • For listed contracts, verify OCC acceptance, product specifications, exercise style, assignment, settlement value, adjustment memos, and broker cutoffs.
  • Calculate current and future exposure under market and counterparty-credit stress, including wrong-way risk.
  • Stress collateral calls, thresholds, minimum transfer amounts, haircuts, concentration limits, substitution, and settlement delay.
  • Use independent valuation inputs and document curves, volatility surfaces, correlations, dividends, rates, and model version.
  • Obtain executable unwind or replacement quotations; an accounting mark is not exit liquidity.
  • Evaluate transfer restrictions, consent, novation, early termination, break costs, and partial unwind rights.
  • Map operational notices, payment dates, exercise procedures, business-day conventions, and fallback calculations.
  • Aggregate exposure by counterparty and netting set; similar trades are not necessarily legally nettable.
  • Use qualified legal, accounting, tax, treasury, and derivatives expertise for bilateral documentation.

“Listed options have no counterparty risk.” Central clearing manages and reallocates the risk through rules and resources; it does not make the system or members incapable of default.

“OTC options are always illiquid and uncleared.” Liquidity depends on contract and counterparties, and some OTC products may have clearing arrangements; the actual path must be verified.

“Customization produces a perfect hedge.” It can reduce contractual mismatch while leaving model, basis, credit, funding, legal, and operational risks.